Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group Study.

Levels of accumulation of methotrexate polyglutamates were measured in vitro in lymphoblasts obtained at diagnosis from children with B-progenitor cell acute lymphoblastic leukemia (pro-B ALL). They were compared to numerical and structural chromosomal abnormalities present in these leukemic cells. In a series of 95 patients, the percent with high lymphoblast methotrexate polyglutamate levels increased with the increase in modal number of total chromosomes (p<0.001). Thus, lymphoblast methotrexate polyglutamate accumulation appeared to be closely linked to the extent of hyperdiploidy in childhood pro-B ALL. Lymphoblasts from 35 (88%) of the 40 children with hyperdiploid (>50 chromosomes) and 23 (88%) of 26 with hyperdiploid (DNA Index >1.16) pro-B ALL accumulated high levels of methotrexate polyglutamate, suggesting that they were more sensitive to methotrexate cytotoxicity. While children with hyperdiploid (DNA Index >1.16) pro-B ALL have a good prognosis, those with trisomies of both chromosomes 4 and 10, almost all of whom are hyperdiploid, have an even better outcome. There was no significant difference in methotrexate polyglutamate levels in lymphoblasts from 19 children with and 21 without trisomies of both chromosomes 4 and 10 (p = 0.25). The improved response to multi-agent chemotherapy conferred by the presence of trisomies of both chromosomes 4 and 10 in such patients may be due to increased sensitivity of their lymphoblasts to one or more anti-leukemic agents in addition to methotrexate.

[1]  M. Relling,et al.  Clinical pharmacodynamic studies of high-dose methotrexate in acute lymphocytic leukemia. , 2009, NCI monographs : a publication of the National Cancer Institute.

[2]  E. Schneider,et al.  Human gamma-glutamyl hydrolase: cloning and characterization of the enzyme expressed in vitro. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  F. Behm,et al.  Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. , 1996, Leukemia.

[4]  P. Meltzer,et al.  Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. , 1995, Cancer research.

[5]  L. Matherly,et al.  Isolation of Human cDNAs That Restore Methotrexate Sensitivity and Reduced Folate Carrier Activity in Methotrexate Transport-defective Chinese Hamster Ovary Cells (*) , 1995, The Journal of Biological Chemistry.

[6]  W. Flintoff,et al.  Isolation of a Human cDNA That Complements a Mutant Hamster Cell Defective in Methotrexate Uptake (*) , 1995, The Journal of Biological Chemistry.

[7]  R. Pieters,et al.  Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study. , 1995, Blood.

[8]  V. Ganapathy,et al.  Molecular cloning of the human placental folate transporter. , 1995, Biochemical and biophysical research communications.

[9]  H. Lenz,et al.  Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by the polymerase chain reaction: marked variation of expression among leukemia patients. , 1994, Oncology research.

[10]  M. Relling,et al.  Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. , 1994, The Journal of clinical investigation.

[11]  M. Relling,et al.  Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia , 1994 .

[12]  A. Look,et al.  Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1992, Blood.

[13]  C. Rubin,et al.  Formation of a hyperdiploid karyotype in childhood acute lymphoblastic leukemia. , 1992, Blood.

[14]  A. Look,et al.  Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. , 1992, Blood.

[15]  A. Nakagawara,et al.  Molecular Basis of Clinical Heterogeneity in Neuroblastoma , 1992, The American journal of pediatric hematology/oncology.

[16]  F. Behm,et al.  Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. , 1992, Blood.

[17]  L. Frankel,et al.  Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Jonathan J. Shuster,et al.  Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study , 1990 .

[19]  J. Shuster,et al.  Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia: a pilot prognostic factor analysis. , 1990, Blood.

[20]  James T. Lin,et al.  Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug. , 1988, Cancer research.

[21]  M. Relling,et al.  Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemia. , 1987, The Journal of pediatrics.

[22]  D. Pinkel.  General motors cancer research foundation prizes Charles F. Kettering prize curing children of leukemia , 1987 .

[23]  S L George,et al.  Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect. , 1986, The New England journal of medicine.

[24]  D. Rodbard,et al.  Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates. , 1985, The Journal of biological chemistry.

[25]  C. Allegra,et al.  Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Sallan,et al.  Comparative analysis of treatment programs for childhood acute lymphoblastic leukemia. , 1985, Seminars in oncology.

[27]  G. Curt,et al.  Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow. , 1985, The Journal of clinical investigation.

[28]  K. Cowan,et al.  A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamates. , 1984, The Journal of biological chemistry.

[29]  B. Chabner,et al.  Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase. , 1983, The Journal of clinical investigation.

[30]  F. Balis,et al.  Pharmacokinetics of oral methotrexate in children. , 1983, Cancer research.

[31]  A. Look,et al.  Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood acute leukemia. , 1982, Blood.

[32]  D. W. Fry,et al.  Rapid formation of poly-gamma-glutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro. , 1982, The Journal of biological chemistry.

[33]  J. Goldie,et al.  A methotrexate insensitive variant of folate reductase present in two lines of methotrexate-resistant L5178Y cells. , 1980, European journal of cancer.

[34]  W. Flintoff,et al.  Methotrexate-resistant Chinese hamster ovary cells contain a dihydrofolate reductase with an altered affinity for methotrexate. , 1980, Biochemistry.

[35]  D. Rosenblatt,et al.  Prolonged inhibition of DNA synthesis associated with the accumulation of methotrexate polyglutamates by cultured human cells. , 1978, Molecular pharmacology.

[36]  J. Bertino,et al.  Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. , 1978, The Journal of biological chemistry.

[37]  V. Whitehead.  Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells. , 1977, Cancer research.

[38]  E. Lehmann,et al.  Nonparametrics: Statistical Methods Based on Ranks , 1976 .

[39]  R. Adamson,et al.  Stoichiometric inhibition of mammalian dihydrofolate reductase by the γ-glutamyl metabolite of methotrexate, 4-amino-4-deoxy-N10-methylpteroylglutamyl-γ-glutamate , 1975 .

[40]  G. A. Fischer.  Detective transport of amethopterin (methotrexate) as a mechanism of resistance to the antimetabolite in L5178Y leukemic cells. , 1962, Biochemical pharmacology.

[41]  A. Look,et al.  Translocations involving chromosome 12p11-13, methotrexate metabolism, and outcome in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[42]  M. Relling,et al.  Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate. , 1996, The Journal of clinical investigation.

[43]  P. Steinherz,et al.  Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia. , 1992, Blood.

[44]  B. Shane.  Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. , 1989, Vitamins and hormones.

[45]  Rivera Gk,et al.  Controversies in the management of childhood acute lymphoblastic leukemia: treatment intensification, CNS leukemia, and prognostic factors , 1987 .

[46]  D. Rosenblatt,et al.  Methotrexate polyglutamate synthesis in lymphoblasts from children with acute lymphoblastic leukemia. , 1987, Developmental pharmacology and therapeutics.

[47]  J. Schornagel,et al.  Resistance to methotrexate due to gene amplification in a patient with acute leukemia. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  R. Schimke,et al.  Gene amplification in a leukemic patient treated with methotrexate. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  A. Craft,et al.  Methotrexate absorption in children with acute lymphoblastic leukemia. , 1981, Cancer treatment reports.

[50]  R. Taylor,et al.  Chromosomal assignment of the gene for folylpolyglutamate synthetase to human chromosome 9. , 1980, Cytogenetics and cell genetics.

[51]  J. Galivan.  Evidence for the cytotoxic activity of polyglutamate derivatives of methotrexate. , 1980, Molecular pharmacology.

[52]  H. Toutenburg,et al.  Lehmann, E. L., Nonparametrics: Statistical Methods Based on Ranks, San Francisco. Holden‐Day, Inc., 1975. 480 S., $ 22.95 . , 1977 .